Target 1Y
Login to View
Target 6M
Login to View
Valuation
Login to View
Max Portfolio %
Login to View
TSVT RSI Chart
Valuation
Login to View
Max Portfolio %
Login to View
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Target 1Y
Login to View
Target 6M
Login to View
How 2seventy bio, Inc. generates revenue and covers its expenses, based on the latest reported earnings.
Historical Charts for Stock Metrics
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2025 | 48.4M | - | - | - |
| 2024 | 71.2M | 44.1M | 45.6M | 37.9M |
| 2023 | 124.7M | 147.3M | 145.9M | 100.4M |
| 2022 | 51.0M | 57.2M | 51.4M | 91.5M |
| 2021 | 199.7M | 151.3M | 102.9M | 54.5M |
| 2020 | - | - | 146.2M | 248.1M |
| 2019 | - | - | - | 44.3M |
| CEO | Mr. Nick Leschly |
|---|---|
| WEBSITE | 2seventybio.com |
| SECTOR | Healthcare |
| INDUSTRY | Biotechnology |
| EMPLOYEES | 425 |